These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30390443)

  • 1. Neuroticism modulates mood responses to pharmacological sex hormone manipulation in healthy women.
    Stenbæk DS; Budtz-Jørgensen E; Pinborg A; Jensen PS; Frokjaer VG
    Psychoneuroendocrinology; 2019 Jan; 99():251-256. PubMed ID: 30390443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex hormone manipulation slows reaction time and increases labile mood in healthy women.
    Stenbæk DS; Fisher PM; Budtz-Jørgensen E; Pinborg A; Hjordt LV; Jensen PS; Knudsen GM; Frokjaer VG
    Psychoneuroendocrinology; 2016 Jun; 68():39-46. PubMed ID: 26943343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mental distress and personality in women undergoing GnRH agonist versus GnRH antagonist protocols for assisted reproductive technology.
    Stenbæk DS; Toftager M; Hjordt LV; Jensen PS; Holst KK; Bryndorf T; Holland T; Bogstad J; Pinborg A; Hornnes P; Frokjaer VG
    Hum Reprod; 2015 Jan; 30(1):103-10. PubMed ID: 25398970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-Steroid Hormone Manipulation Reduces Brain Response to Reward.
    Macoveanu J; Henningsson S; Pinborg A; Jensen P; Knudsen GM; Frokjaer VG; Siebner HR
    Neuropsychopharmacology; 2016 Mar; 41(4):1057-65. PubMed ID: 26245498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Serotonin Transporter Changes in Depressive Responses to Sex-Steroid Hormone Manipulation: A Positron Emission Tomography Study.
    Frokjaer VG; Pinborg A; Holst KK; Overgaard A; Henningsson S; Heede M; Larsen EC; Jensen PS; Agn M; Nielsen AP; Stenbæk DS; da Cunha-Bang S; Lehel S; Siebner HR; Mikkelsen JD; Svarer C; Knudsen GM
    Biol Psychiatry; 2015 Oct; 78(8):534-43. PubMed ID: 26004162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadal steroids and affective symptoms during in vitro fertilization: implication for reproductive mood disorders.
    Bloch M; Aharonov I; Ben Avi I; Schreiber S; Amit A; Weizman A; Azem F
    Psychoneuroendocrinology; 2011 Jul; 36(6):790-6. PubMed ID: 21106297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal volume changes in a pharmacological sex-hormone manipulation risk model for depression in women.
    Borgsted C; Hoegsted E; Henningsson S; Pinborg A; Ganz M; Frokjaer VG
    Horm Behav; 2022 Sep; 145():105234. PubMed ID: 35905507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologically Induced Sex Hormone Fluctuation Effects on Resting-State Functional Connectivity in a Risk Model for Depression: A Randomized Trial.
    Fisher PM; Larsen CB; Beliveau V; Henningsson S; Pinborg A; Holst KK; Jensen PS; Svarer C; Siebner HR; Knudsen GM; Frokjaer VG
    Neuropsychopharmacology; 2017 Jan; 42(2):446-453. PubMed ID: 27649641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for oestrogen sensitivity in perinatal depression: pharmacological sex hormone manipulation study.
    Mehta D; Rex-Haffner M; Søndergaard HB; Pinborg A; Binder EB; Frokjaer VG
    Br J Psychiatry; 2019 Sep; 215(3):519-527. PubMed ID: 30457060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mood Instability and Trait Anxiety as Distinct Components of Eysenckian Neuroticism With Differential Relations to Impulsivity and Risk Taking.
    Peters EM; Bowen R; Balbuena L
    J Pers Assess; 2020; 102(3):337-347. PubMed ID: 30907661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological sex hormone manipulation as a risk model for depression.
    Frokjaer VG
    J Neurosci Res; 2020 Jul; 98(7):1283-1292. PubMed ID: 32399989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between self-reported childhood traumatic experiences, attachment style, neuroticism and features of borderline personality disorders in patients with mood disorders.
    Baryshnikov I; Joffe G; Koivisto M; Melartin T; Aaltonen K; Suominen K; Rosenström T; Näätänen P; Karpov B; Heikkinen M; Isometsä E
    J Affect Disord; 2017 Mar; 210():82-89. PubMed ID: 28024223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of emotional processing in depressive responses to sex-hormone manipulation: a pharmacological fMRI study.
    Henningsson S; Madsen KH; Pinborg A; Heede M; Knudsen GM; Siebner HR; Frokjaer VG
    Transl Psychiatry; 2015 Dec; 5(12):e688. PubMed ID: 26624927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of a big five personality questionnaire to the symptoms of affective disorders.
    Wilks Z; Perkins AM; Cooper A; Pliszka B; Cleare AJ; Young AH
    J Affect Disord; 2020 Dec; 277():14-20. PubMed ID: 32777603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Does the French Big Five Inventory evaluate facets other than the Big Five factors?].
    Courtois R; Petot JM; Lignier B; Lecocq G; Plaisant O
    Encephale; 2018 Jun; 44(3):208-214. PubMed ID: 28364967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the relationship between suicidality, current depressed mood, personality, and cognitive factors.
    Cameron S; Brown VJ; Dritschel B; Power K; Cook M
    Psychol Psychother; 2017 Dec; 90(4):530-549. PubMed ID: 28296207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult attachment's unique contribution in the prediction of postpartum depressive symptoms, beyond personality traits.
    Axfors C; Sylvén S; Ramklint M; Skalkidou A
    J Affect Disord; 2017 Nov; 222():177-184. PubMed ID: 28709025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the role of testosterone in the cerebellum link to neuroticism: From adolescence to early adulthood.
    Schutter DJLG; Meuwese R; Bos MGN; Crone EA; Peper JS
    Psychoneuroendocrinology; 2017 Apr; 78():203-212. PubMed ID: 28214680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial risk for mood disorder and the personality risk factor, neuroticism, interact in their association with frontolimbic serotonin 2A receptor binding.
    Frokjaer VG; Vinberg M; Erritzoe D; Baaré W; Holst KK; Mortensen EL; Arfan H; Madsen J; Jernigan TL; Kessing LV; Knudsen GM
    Neuropsychopharmacology; 2010 Apr; 35(5):1129-37. PubMed ID: 20043006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder.
    Frokjaer VG; Mortensen EL; Nielsen FA; Haugbol S; Pinborg LH; Adams KH; Svarer C; Hasselbalch SG; Holm S; Paulson OB; Knudsen GM
    Biol Psychiatry; 2008 Mar; 63(6):569-76. PubMed ID: 17884017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.